Welcome Italia selects ADVA FSP 3000 for ultra-high-capacity enterprise services
30.7.2019 09:55:00 EEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Welcome Italia has selected its FSP 3000 and ALM fiber monitoring solution to enable assured high-capacity enterprise services throughout Italy. The technology partnership will create scalable fiber optic infrastructure and provide the security and reliability needed for IoT and 5G applications. Stretching over 2,500km and connecting Welcome Italia’s two main data centers, the new network features ADVA’s colorless, directionless and flexgrid multi-degree ROADMs, enabling automatic traffic rerouting for enhanced availability. The solution has also been primed for the comprehensive, low-latency security of ADVA’s ConnectGuard™ Optical encryption technology. ADVA’s partner Sirti is installing the network and will also provide ongoing maintenance and support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190729005500/en/
Image ADVA's FSP 3000 and ALM fiber monitoring solution will play a key role in delivering assured high-capacity enterprise services throughout Italy (Photo: Business Wire)
”Our aim is to harness the best technology available to provide the ultimate service for our enterprise customers. ADVA’s scalable and efficient solution not only empowers us to deliver fast, flexible and secure business continuity services, but it also helps us reduce cost and lay the foundation for future growth,” commented Nicola Gallico, network manager and founder, Welcome Italia. “This deployment provides concrete answers to the most urgent needs of Italian enterprises. It means they can rely on high-speed, low-latency connectivity backed up by a fully redundant network architecture and protected by real-time fiber monitoring. With the support of the ADVA and Sirti team, we’ll continue to help our customers develop their businesses and seize new opportunities.”
Welcome Italia’s new backbone network serves enterprise clients throughout Italy with points of presence spread across the country. Built on the ADVA FSP 3000, it simplifies network operations and helps to reduce capital and operational expenditure. With its modular architecture, the FSP 3000 gives Welcome Italia the freedom to expand its network as soon as it’s required. The solution is also monitored by the ADVA ALM, which gives real-time insight into the integrity and performance of Welcome Italia’s fiber infrastructure, significantly improving robustness and efficiency. What’s more, the complete network is managed by Ensemble Controller, which combines efficiency in manual operations with programmatic control. This advanced management and domain control solution supports users while also enabling intelligent algorithms to gather data and take autonomous action.
“Welcome Italia chose our technology because it’s the ideal tool for meeting the needs of enterprise customers. It provides superb scalability and cost efficiency, enabling high-speed services that are secure and fully future proof. We’re pleased to be working closely with Welcome Italia’s team to ensure that businesses in this region can capitalize on the most advanced latency-sensitive applications as soon as they hit the market,” commented Marcello Forti, VP, sales, ADVA. “With the flexibility of our ROADM technology and our ALM providing complete fiber network visibility, this solution gives Welcome Italia a new level of agility and reliability. For enterprises across Italy, Welcome Italia’s new network will be the key to harnessing the business opportunities of the IoT.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at: www.advaoptical.com.
About Welcome Italia
Welcome Italia is an Italian telecommunication operator that simplifies your company’s communications with an integrated offer of mobile and fixed line services called Vianova. Vianova combines traditional services, like telephony and ultra-broadband data access, with unified communication and collaboration services like cloud, centrex, mail, meetings, Wi-Fi calls, busy calls, SIM manager. Welcome Italia is also appreciated for the quality of its customer care that answers calls in three rings. Two property data centers host the redundant infrastructure that allows the supply of services for the whole Welcome Italia Group. www.welcomeitalia.it/en
Published by:
ADVA Optical Networking SE, Munich, Germany
www.advaoptical.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190729005500/en/
Contact information
For press:
Gareth Spence
t +44 1904 699 358
public-relations@advaoptical.com
For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@advaoptical.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 09:10:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera
Azafaros to Present at BIO International Convention 202615.6.2026 08:00:00 EEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 07:05:00 EEST | Press release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom